Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
OtherAccelerated Communication

A NEW CLASS OF CYP2C9 INHIBITORS: PROBING 2C9 SPECIFICITY WITH HIGH-AFFINITY BENZBROMARONE DERIVATIVES

Charles W. Locuson II, Jan L. Wahlstrom, Denise A. Rock, Dan A. Rock and Jeffrey P. Jones
Drug Metabolism and Disposition July 2003, 31 (7) 967-971; DOI: https://doi.org/10.1124/dmd.31.7.967
Charles W. Locuson II
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jan L. Wahlstrom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Denise A. Rock
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dan A. Rock
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeffrey P. Jones
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 31 no. 7 967-971
DOI 
https://doi.org/10.1124/dmd.31.7.967
PubMed 
12814975

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received February 24, 2003
  • Accepted March 19, 2003
  • Published online July 1, 2003.

Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Charles W. Locuson II,
  2. Jan L. Wahlstrom,
  3. Denise A. Rock,
  4. Dan A. Rock and
  5. Jeffrey P. Jones
  1. Washington State University, School of Molecular Biosciences (C.W.L. II) and Department of Chemistry (De.A.R., Da.A.R., J.P.J.), Pullman, Washington; and Camitro Corp., Redwood City, California (J.L.W.)
  1. Address correspondence to:
    Jeffrey P. Jones, Washington State University, Department of Chemistry, Pullman, WA 99164-4630. E-mail: jpj{at}wsu.edu
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: June 2003 to June 2022

AbstractFullPdf
Jun 20035839107
Jul 2003375584
Aug 2003152931
Sep 2003162623
Oct 2003182212
Nov 200392113
Dec 200312194
Jan 200412268
Feb 20047189
Mar 2004131516
Apr 2004113813
May 200411268
Jun 2004194320
Jul 2004163029
Aug 2004252319
Sep 200422298
Oct 2004184529
Nov 2004175118
Dec 2004193317
Jan 2005214721
Feb 2005132622
Mar 2005103821
Apr 20057188
May 2005103618
Jun 200593621
Jul 200593826
Aug 200533113
Sep 200564817
Oct 200583816
Nov 200583314
Dec 200563514
Jan 200674213
Feb 200643612
Mar 200662714
Apr 200611918
May 200672413
Jun 200632710
Jul 20063199
Aug 200652015
Sep 20065189
Oct 2006151923
Nov 200682213
Dec 20067149
Jan 200742914
Feb 20074179
Mar 20074227
Apr 200772522
May 20075288
Jun 20073198
Jul 200782017
Aug 200792516
Sep 20074246
Oct 20073198
Nov 20072129
Dec 20075179
Jan 200841311
Feb 200811712
Mar 200831910
Apr 200831811
May 200810184
Jun 200812013
Jul 200871912
Aug 200871810
Sep 20086168
Oct 20081105
Nov 200891613
Dec 2008484
Jan 200981616
Feb 200922014
Mar 200913208
Apr 20094127
May 20090147
Jun 20094133
Jul 2009494
Aug 20092116
Sep 20098132
Oct 200961112
Nov 200971715
Dec 200961217
Jan 2010253
Feb 201010199
Mar 201081210
Apr 20105165
May 20109126
Jun 201025298
Jul 2010141511
Aug 20105269
Sep 201051910
Oct 201013172
Nov 2010172510
Dec 20104156
Jan 20116175
Feb 201124347
Mar 201111188
Apr 2011181614
May 20119215
Jun 20113152
Jul 2011121119
Aug 2011122710
Sep 201110315
Oct 20119219
Nov 201115196
Dec 2011173012
Jan 20127255
Feb 201220299
Mar 2012263217
Apr 2012194815
May 201216169
Jun 2012192411
Jul 2012111310
Aug 2012161815
Sep 2012152910
Oct 2012132018
Nov 2012272714
Dec 2012161813
Jan 2013162010
Feb 2013382811
Mar 201315236
Apr 2013283215
May 2013291411
Jun 20133102
Jul 201312204
Aug 2013875
Sep 20131334
Oct 20131796
Nov 201315136
Dec 2013774
Jan 20147114
Feb 20148256
Mar 201411204
Apr 201423124
May 201428126
Jun 2014092
Jul 20147147
Aug 201411376
Sep 20147117
Oct 20141053
Nov 201414127
Dec 2014262
Jan 201517126
Feb 20157114
Mar 201518108
Apr 2015585
May 20151192
Jun 20151865
Jul 20158116
Aug 20157105
Sep 20151261
Oct 2015843
Nov 2015951
Dec 20154117
Jan 2016354
Feb 2016422
Mar 201618313
Apr 2016058
May 20167523
Jun 20163138
Jul 2016964
Aug 20163143
Sep 20162117
Oct 20163247
Nov 20161144
Dec 2016120
Jan 20170123
Feb 20171103
Mar 20170131
Apr 20170125
May 201701812
Jun 20172134
Jul 20170142
Aug 20170199
Sep 201713110
Oct 20171417
Nov 20170347
Dec 201702414
Jan 201812734
Feb 201831811
Mar 201831746
Apr 20181865
May 20181864
Jun 20184592
Jul 20182363
Aug 20180255
Sep 20182264
Oct 20180415
Nov 20180427
Dec 20183572
Jan 20194663
Feb 20193611
Mar 20193000
Apr 20191610
May 20191210
Jun 2019904
Jul 20191100
Aug 20191211
Sep 20191800
Oct 20191224
Nov 20191501
Dec 20191021
Jan 20202221
Feb 20201021
Mar 2020722
Apr 20201300
May 20201111
Jun 2020911
Jul 20201520
Aug 2020522
Sep 20201510
Oct 20201310
Nov 20201000
Dec 20201710
Jan 202118101
Feb 20211961
Mar 20211322
Apr 20211120
May 20211530
Jun 20211240
Jul 20211463
Aug 20211150
Sep 2021521
Oct 2021621
Nov 20211510
Dec 20211710
Jan 20221230
Feb 2022910
Mar 2022620
Apr 20221220
May 2022910
Jun 20221731

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 31 (7)
Drug Metabolism and Disposition
Vol. 31, Issue 7
1 Jul 2003
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
A NEW CLASS OF CYP2C9 INHIBITORS: PROBING 2C9 SPECIFICITY WITH HIGH-AFFINITY BENZBROMARONE DERIVATIVES
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
OtherAccelerated Communication

A NEW CLASS OF CYP2C9 INHIBITORS: PROBING 2C9 SPECIFICITY WITH HIGH-AFFINITY BENZBROMARONE DERIVATIVES

Charles W. Locuson, Jan L. Wahlstrom, Denise A. Rock, Dan A. Rock and Jeffrey P. Jones
Drug Metabolism and Disposition July 1, 2003, 31 (7) 967-971; DOI: https://doi.org/10.1124/dmd.31.7.967

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
OtherAccelerated Communication

A NEW CLASS OF CYP2C9 INHIBITORS: PROBING 2C9 SPECIFICITY WITH HIGH-AFFINITY BENZBROMARONE DERIVATIVES

Charles W. Locuson, Jan L. Wahlstrom, Denise A. Rock, Dan A. Rock and Jeffrey P. Jones
Drug Metabolism and Disposition July 1, 2003, 31 (7) 967-971; DOI: https://doi.org/10.1124/dmd.31.7.967
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Experimental Procedures
    • Results and Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Use of CYP Transgenic Mouse Models
  • Nonlinear Metabolite Kinetics of Verapamil
  • Production of Recombinant hsa-mir-27b
Show more ACCELERATED COMMUNICATIONS

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics